RxDoctor Payments Data

Clinton Merrill

Hematology & Oncology · Lander, WYNPI 1992707285

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $327 and has fallen 71.8% since, to $92 in 2023.

$913in general payments, 2019–2025

Across 53 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$151
  • Merck$139
  • Novartis$73
  • EMD Serono, Inc.$59
  • Incyte Corporation$48
  • CTI Biopharma Corp.$42
  • plus $401 from 15 others

What the payments were for

  • Food & beverage$88997%
  • Education$243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few hematology & oncology providers in Wyomingto place this figure against a meaningful peer group, so we don't.

Other hematology & oncology in Lander

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →